{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:05:19Z","timestamp":1783386319091,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.exer.2020.108031","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T01:57:09Z","timestamp":1586224629000},"page":"108031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Primate model of chronic retinal neovascularization and vascular leakage"],"prefix":"10.1016","volume":"195","author":[{"given":"Chintan","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Goody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Kurian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donnicia","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori-Ann","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2020.108031_bib1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2020.108031_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"Muller cells in the healthy and diseased retina","volume":"25","author":"Bringmann","year":"2006","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2020.108031_bib3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1167\/iovs.17-22897","article-title":"Aflibercept action in a rabbit model of chronic retinal neovascularization: reversible inhibition of pathologic leakage with dose-dependent duration","volume":"59","author":"Cao","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108031_bib4","series-title":"Retinal Pharmacotherapeutics","first-page":"189","article-title":"Retinal diseases amenable to pharmacotherapy","author":"Charbel Issa","year":"2016"},{"key":"10.1016\/j.exer.2020.108031_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.visres.2017.03.013","article-title":"Muller cells and diabetic retinopathy","volume":"139","author":"Coughlin","year":"2017","journal-title":"Vision Res"},{"key":"10.1016\/j.exer.2020.108031_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.117.6.821","article-title":"Muller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacualr retinoschisis","volume":"117","author":"Gass","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108031_bib7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/jop.2011.0164","article-title":"The use of the African green monkey as a preclinical model for ocular pharmacokinetic studies","volume":"28","author":"Glogowski","year":"2012","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.exer.2020.108031_bib8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.preteyeres.2010.05.003","article-title":"Animal models of choroidal and retinal neovascularization","volume":"29","author":"Grossniklaus","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2020.108031_bib9","first-page":"810","article-title":"[Structural changes in retinal glial cells following the intravitreal injection of DL-alpha-aminoadipic acid]","volume":"86","author":"Ishikawa","year":"1982","journal-title":"Nippon. Ganka Gakkai Zasshi"},{"key":"10.1016\/j.exer.2020.108031_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0306-4522(93)90080-Y","article-title":"Cystine\/glutamate antiporter expression in retinal Muller glial cells: implications for DL-alpha-aminoadipate toxicity","volume":"57","author":"Kato","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.exer.2020.108031_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0306-4522(90)90357-A","article-title":"Gliotoxic effects of alpha-aminoadipic acid isomers on the carp retina: a long term observation","volume":"36","author":"Kato","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.exer.2020.108031_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.exer.2018.05.027","article-title":"A novel model of persistent retinal neovascularization for the development of sustained anti-VEGF therapies","volume":"174","author":"Li","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2020.108031_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-3806(81)90097-3","article-title":"Induction of glutamine synthetase in embryonic neural retina: its suppression by the gliatoxic agent alpha-aminoadipic acid","volume":"227","author":"Linser","year":"1981","journal-title":"Brain Res."},{"key":"10.1016\/j.exer.2020.108031_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/tvst.6.5.9","article-title":"Evaluation of a sustained-release prednisolone acetate biodegradable subconjunctival implant in a non-human primate model","volume":"6","author":"Liu","year":"2017","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.exer.2020.108031_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/ilar\/ilx009","article-title":"Nonhuman primate studies to advance vision science and prevent blindness","volume":"58","author":"Mustari","year":"2017","journal-title":"ILAR J."},{"key":"10.1016\/j.exer.2020.108031_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1152\/jn.1984.51.1.164","article-title":"Model of electroretinogram b-wave generation: a test of the K+ hypothesis","volume":"51","author":"Newman","year":"1984","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.exer.2020.108031_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00234911","article-title":"Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system","volume":"14","author":"Olney","year":"1971","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.exer.2020.108031_bib18","series-title":"High-quality Histology of Cleared Tissue Samples by Polygon-Based Multiphoton Microscopy, Microscopy Histopathology and Analytics","author":"Olson","year":"2018"},{"key":"10.1016\/j.exer.2020.108031_bib19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0014-4835(79)90044-7","article-title":"Destruction of Muller cells in the adult rat by intravitreal injection of D,L-alpha-aminoadipic acid. An electron microscopic study","volume":"28","author":"Pedersen","year":"1979","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2020.108031_bib33","series-title":"ImageJ","author":"Rasband","year":"1997"},{"key":"10.1016\/j.exer.2020.108031_bib20","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1167\/iovs.18-25307","article-title":"Functional characterization of abicipar-pegol, an anti-VEGF DARPin therapeutic that potently inhibits angiogenesis and vascular permeability","volume":"59","author":"Rodrigues","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108031_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ng.3799","article-title":"Genome-wide analyses identify common variants associated with macular telangiectasia type 2","volume":"49","author":"Scerri","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exer.2020.108031_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2013.08.011","article-title":"Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies","volume":"121","author":"Schmidt-Erfurth","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108031_bib23","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/jnr.22317","article-title":"Retinal vascular changes after glial disruption in rats","volume":"88","author":"Shen","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.exer.2020.108031_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1167\/iovs.10-6033","article-title":"Submacular DL-alpha-aminoadipic acid eradicates primate photoreceptors but does not affect luteal pigment or the retinal vasculature","volume":"52","author":"Shen","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108031_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.visres.2016.07.005","article-title":"Restoration of visual performance by d-serine in models of inner and outer retinal dysfunction assessed using sweep VEP measurements in the conscious rat and rabbit","volume":"127","author":"Staubli","year":"2016","journal-title":"Vision Res"},{"key":"10.1016\/j.exer.2020.108031_bib26","series-title":"Gamma-aminobutyric Acid and glycine as Retinal Neurotransmitters","author":"Voaden","year":"1976"},{"key":"10.1016\/j.exer.2020.108031_bib27","series-title":"Assessing Ocular Toxicology in Laboratory Animals","author":"Weir","year":"2013"},{"key":"10.1016\/j.exer.2020.108031_bib28","first-page":"240","article-title":"Effects of intravitreally injected DL-alpha-aminoadipic acid on the c-wave of the D.C.-recorded electroretinogram in albino rabbits","volume":"23","author":"Welinder","year":"1982","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108031_bib29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1139\/y04-067","article-title":"Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes","volume":"82","author":"Wijekoon","year":"2004","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.exer.2020.108031_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archopht.124.4.450","article-title":"Idiopathic macular telangiectasia","volume":"124","author":"Yannuzzi","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108031_bib31","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1021\/pr200815c","article-title":"Amine metabolomics of hyperglycemic endothelial cells using capillary LC-MS with isobaric tagging","volume":"10","author":"Yuan","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.exer.2020.108031_bib32","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43598","article-title":"Human macular Muller cells rely more on serine biosynthesis to combat oxidative stress than those from the periphery","volume":"8","author":"Zhang","year":"2019","journal-title":"Elife"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519308127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519308127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:03:46Z","timestamp":1757999026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483519308127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":33,"alternative-id":["S0014483519308127"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2020.108031","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primate model of chronic retinal neovascularization and vascular leakage","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2020.108031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Virscio, Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108031"}}